Alberto Servetto

2.2k total citations · 1 hit paper
56 papers, 897 citations indexed

About

Alberto Servetto is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Alberto Servetto has authored 56 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 29 papers in Pulmonary and Respiratory Medicine and 20 papers in Molecular Biology. Recurrent topics in Alberto Servetto's work include Lung Cancer Treatments and Mutations (12 papers), Cancer Genomics and Diagnostics (8 papers) and Advanced Breast Cancer Therapies (8 papers). Alberto Servetto is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Cancer Genomics and Diagnostics (8 papers) and Advanced Breast Cancer Therapies (8 papers). Alberto Servetto collaborates with scholars based in Italy, United States and Spain. Alberto Servetto's co-authors include Luigi Formisano, Roberto Bianco, Fabiana Napolitano, Roberta Marciano, Sabino De Placido, Daniela Esposito, Antonio Santaniello, Stefania Belli, Carlos L. Arteaga and Roberta Rosa and has published in prestigious journals such as Nature Communications, JNCI Journal of the National Cancer Institute and Cancer Cell.

In The Last Decade

Alberto Servetto

50 papers receiving 891 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of FGFR3 in bladder cancer: Treatment landscape and future challenges

2023 101 citations Fabiana Napolitano, Daniela Esposito et al. Cancer Treatment Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alberto Servetto Italy	16	512	394	271	208	112	56	897
François Ringeisen France	14	517 1.0×	373 0.9×	305 1.1×	175 0.8×	85 0.8×	33	899
Cuiju Tang China	14	382 0.7×	340 0.9×	240 0.9×	178 0.9×	81 0.7×	47	853
Wen Liu China	15	407 0.8×	525 1.3×	210 0.8×	182 0.9×	86 0.8×	59	885
Zizhen Feng China	12	671 1.3×	272 0.7×	140 0.5×	145 0.7×	137 1.2×	23	1.0k
Maher N. Younes United States	19	517 1.0×	498 1.3×	158 0.6×	169 0.8×	95 0.8×	21	1.1k
Xinmin Zhao China	13	263 0.5×	354 0.9×	259 1.0×	138 0.7×	71 0.6×	47	666
Mónica Musteanu Spain	14	415 0.8×	552 1.4×	149 0.5×	181 0.9×	107 1.0×	32	972
Gnana P. Krishnamoorthy United States	12	457 0.9×	449 1.1×	178 0.7×	137 0.7×	97 0.9×	16	1.3k
Sujatha Jagadeeswaran United States	12	465 0.9×	360 0.9×	169 0.6×	197 0.9×	74 0.7×	16	973
Takumi Yamabuki Japan	13	894 1.7×	317 0.8×	197 0.7×	220 1.1×	163 1.5×	29	1.2k

Countries citing papers authored by Alberto Servetto

Since Specialization

Citations

This map shows the geographic impact of Alberto Servetto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Servetto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Servetto more than expected).

Fields of papers citing papers by Alberto Servetto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Servetto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Servetto. The network helps show where Alberto Servetto may publish in the future.

Co-authorship network of co-authors of Alberto Servetto

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Servetto. A scholar is included among the top collaborators of Alberto Servetto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Servetto. Alberto Servetto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pellegrino, Sara, et al.. (2025). Prognostic Value of Tumor Dissemination (Dmax) Derived from Basal 18F-FDG Positron Emission Tomography/Computed Tomography in Patients with Advanced Non-Small-Cell Lung Cancer. Biomedicines. 13(2). 477–477. 3 indexed citations

Maïo, Massimo Di, Sasha D’Ambrosio, Fabiana Napolitano, et al.. (2025). Censoring in trials testing immunotherapy in advanced cancers: a systematic review and a meta-research study. JNCI Journal of the National Cancer Institute. 118(2). 214–222.

Pellegrino, Sara, Mariarosaria Panico, Alberto Servetto, et al.. (2025). Texture Analysis of 68Ga-DOTATOC PET/CT Images for the Prediction of Outcome in Patients with Neuroendocrine Tumors. Biomedicines. 13(6). 1286–1286. 1 indexed citations

Servetto, Alberto, Biagio Ricciuti, Daniele Marinelli, et al.. (2025). Neoadjuvant vs perioperative chemo-immunotherapy according to pathological response in resectable non-small cell lung cancer: a reconstructed individual patient data meta-analysis. JNCI Journal of the National Cancer Institute. 117(11). 2388–2393. 1 indexed citations

Liguori, Luigi, et al.. (2024). KRAS mutations in advanced non-small cell lung cancer: From biology to novel therapeutic strategies. Critical Reviews in Oncology/Hematology. 205. 104554–104554. 2 indexed citations

Servetto, Alberto, Carmine De Angelis, Grazia Arpino, et al.. (2024). Exploring the interplay between Kaposi's sarcoma and SARS‐CoV‐2 infection: A case series and systematic review. Journal of Medical Virology. 96(8). e29849–e29849.

Liguori, Luigi, Giovanna Polcaro, Valentina Pagliara, et al.. (2024). Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study. Frontiers in Immunology. 15. 1419544–1419544. 3 indexed citations

Servetto, Alberto, et al.. (2024). Malignant granular cell tumor of chest wall: a case report. Frontiers in Oncology. 14. 1465130–1465130.

Belli, Stefania, Ada Pesapane, Alberto Servetto, et al.. (2023). Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancer. British Journal of Cancer. 129(7). 1071–1082. 5 indexed citations

10.

Napolitano, Fabiana, Annachiara Marra, Felice Crocetto, et al.. (2023). Analysis of Health-Related Quality of Life Reporting in Phase III RCTs of Advanced Genitourinary Tumors. Cancers. 15(23). 5703–5703.

11.

Napolitano, Fabiana, Daniela Esposito, Alberto Servetto, et al.. (2023). Role of FGFR3 in bladder cancer: Treatment landscape and future challenges. Cancer Treatment Reviews. 115. 102530–102530. 101 indexed citations breakdown →

12.

Viscardi, Giuseppe, Fabiana Vitiello, Alberto Servetto, et al.. (2022). Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review. Cancers. 14(23). 5810–5810. 4 indexed citations

13.

Viscardi, Giuseppe, Fabiana Napolitano, Antonio Santaniello, et al.. (2022). Health-related quality of life is underestimated and underreported in phase III clinical trials in NSCLC. Lung Cancer. 174. 36–44. 6 indexed citations

14.

Napolitano, Fabiana, Pietro De Placido, Valeria Forestieri, et al.. (2022). Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer. Biomolecules. 12(10). 1394–1394. 12 indexed citations

15.

Servetto, Alberto, Antonio Santaniello, Fabiana Napolitano, et al.. (2022). FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Adenocarcinoma: An Observational Study. Future Oncology. 18(21). 2643–2653. 2 indexed citations

16.

Hanker, Ariella B., Benjamin P. Brown, Jens Meiler, et al.. (2021). Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity. Cancer Cell. 39(8). 1099–1114.e8. 53 indexed citations

17.

Servetto, Alberto, Antonio Santaniello, Fabiana Napolitano, et al.. (2021). Use of FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine for the Treatment of Locally Advanced Pancreatic Adenocarcinoma: A Single Institution Observational Study. Cancers. 13(19). 4939–4939. 3 indexed citations

18.

Servetto, Alberto, Rahul K. Kollipara, Luigi Formisano, et al.. (2021). Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER+ Breast Cancer. Clinical Cancer Research. 27(15). 4379–4396. 44 indexed citations

19.

Drago, Joshua Z., Luigi Formisano, Dejan Juric, et al.. (2019). FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor–Positive (HR+) Breast Cancer. Clinical Cancer Research. 25(21). 6443–6451. 47 indexed citations

20.

Napolitano, Fabiana, Luigi Formisano, Alessandro Giardino, et al.. (2019). Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review. Cancers. 11(7). 981–981. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact